Primary Care in Rochester and Kasson

Mayo Clinic is seeking adult volunteers with Type 2 diabetes to participate in a research study. The purpose of this study is to research which type of over-the-counter fiber supplement, such as Metamucil™ (psyllium) or Benefiber™ (wheat dextrin), has a greater effect on lowering fasting glucose, cholesterol and certain inflammatory markers in the blood. 

You may be eligible to participate if you:

• Receive care through Primary Care in Rochester and Kasson at Mayo Clinic. 
• Have Type 2 Diabetes. 

Remuneration of $20 for visits 1–3 of each in-person study visit and $100 for completing visit 4. You will also receive a parking voucher worth up to $6 for each in-person visit. 

For questions regarding the study, contact the Family Medicine Research Study Coordinators via email at RSTFMSC@mayo.edu or telephone (507-422-6823).

The purpose of this study is to develop ways to reduce hypertension-management-related disparities in the Greater Mankato Area Somali population. 

During the study, you will take part in a 30-minute session on day 1 in which your blood pressure will be measured. You may be contacted to join two 30-minute follow-up sessions (one at 6 weeks and one at 3 months after day 1). During the follow-up sessions you will be asked about your primary care provider and blood pressure control statuses. Your name may be drawn at random to receive health education and a blood pressure monitor. 

You may be eligible to participate if you are: 

• Somali non-pregnant adult (age 18 or older) in the Greater Mankato area who —
  • Shops at the Mankato Halal Stores and/or
  • Attends the Mosque in Mankato

For questions regarding the study contact Mohamed Ibrahim, MBBS, or Erin Westfall, D.O.

The purpose of this study is to learn about the changes in blood clotting proteins as children age. 

The study will consist of an in-person consent visit with the study coordinator and a blood draw. Children are eligible to return to the clinic for annual blood draws until the age of 18. The research blood draw can be coordinated with clinical draws if applicable. All study costs will be covered and will result in no extra charges to you or your child. We will offer payment for your child's participation. 

You may be eligible to participate if: 

• You are < 18 years of age. 
• Are generally healthy.
• Are taking no medications that affect blood clotting. 
• Are willing to come to an in-person visit at Mayo Clinic in Rochester, Minnesota. 

For questions regarding this study, contact Noelle Drapeau (drapeau.noelle2@mayo.edu or 507-266-6397). 

The purpose of this study is to determine if there are certain cells, or biomarkers, in the blood that can help detect the severity of asthma. 

You may be eligible to participate if: 

• You have a diagnosis of asthma and are not actively sick (e.g., Influenza, COVID-19)
• You have a diagnosis of an allergy without recurrent wheezing or an asthma diagnosis and you rare not actively sick (e.g., Influenza, COVID-19)
• If you do not have or are not suspected to have any known upper/lower respiratory disease and are not actively sick (e.g., Influenza, COVID-19)

Once enrolled in this study, participants will be asked to complete a short questionnaire and provide one blood sample. You may be contacted to provide a second sample at a later time. 

Participants also may be asked to participate in a test that measures their breath. They will receive $25 for participating in the breath test. Results of this test will be available in the participants' medical record.

The risks of this study are minor and include pain, bruising, lightheadedness, and/or fainting. Rarely infection at the site of the needle stick may occur. The goal of the study is to gather information and participation will help doctors understand asthma. Information or samples collected for this study will be sent outside of Mayo Clinic for use by the sponsor of this study, Thermo Fisher Scientific. Samples, will be sent and stored without any identifiable information such as your name, Mayo Clinic number, date of birth, etc.

Study participants will receive $25.00 for each blood draw.

For questions regarding this study, contact Doug Jazdewski (jazdzewski.doug@mayo.edu or 507-266-0245). 

Mayo Clinic is seeking to understand how different interventions may help improve communication among providers, the clinic health care team and patients with communication disabilities (CD) during clinical encounters in primary care. 

You may be eligible to participate if: 

• You are age 18 or older. 
• You are a Mayo Clinic patient being seen at the Baldwin clinic or Mayo Family Clinic Southeast in Rochester, Minnesota, and have an upcoming visit with a primary care provider. 
• You have difficulty communicating or a communication disability. 

The estimated time commitment is approximately 15 minutes for the prescreening questions (completed by phone, Patient Online Services or email), and approximately 35-45 minutes for the enrollment visit (completed either in person or remotely by phone, Patient Online Services or email). Compensation will be provided for time spent in the study. 

This study is not designed to treat any illnesses or to directly improve your health. However, you may potentially benefit as the interventions are aimed at improving health care information delivery to patients with difficulty communicating. Anything we learn from this study may benefit patients in the future. 

For questions regarding this study contact the Family Medicine Study Coordinators by email at rstfmsc@mayo.edu or by telephone at 507-422-6823.

The purpose of this study is to measure sulfoconjugates of vitamin D in breast milk. 

You may be eligible to participate if: 

• You are a currently lactating mother. 
• You are two weeks (or greater) post delivery. 
• You have no intentions of weaning your child during the study. 

You will meet with a study team member and have a 12 mL blood draw. During the visit you will express breast milk in a private location and allow the study team will have one-third of an ounce (10 mL) of the freshly expressed breast milk for the research study. You will be supplied with a 28-day dose of Vitamin D3 (5000 IU) that you will take daily throughout the length of the study. 

Approximately 28 days after your initial visit, you will again meet with a study team member to have a 12 mL blood draw, express breast milk in a private location, and allow the study team to have one-third of an ounce (10 mL) of the freshly expressed breast milk for the study. 

We ask that you bring your personal breast pump and collection container(s) to each visit. 

For questions regarding this study, contact the Family Medicine Study Coordinators by email at rstfmc@mayo.edu or by telephone at 507-422-6823. 

Mayo Clinic is seeking adult volunteers with Type 2 diabetes to participate in a research study. The purpose of this study is to research which type of over-the-counter fiber supplement, such as Metamucil™ (psyllium) or Benefiber™ (wheat dextrin), has a greater effect on lowering fasting glucose, cholesterol and certain inflammatory markers in the blood. 

You may be eligible to participate if you:

• Receive care through Primary Care in Rochester and Kasson at Mayo Clinic. 
• Have Type 2 Diabetes. 

Remuneration of $20 for visits 1–3 of each in-person study visit and $100 for completing visit 4. You will also receive a parking voucher worth up to $6 for each in-person visit. 

For questions regarding the study, contact the Family Medicine Research Study Coordinators via email at RSTFMSC@mayo.edu or telephone (507-422-6823).

The purpose of this study is to develop ways to reduce hypertension-management-related disparities in the Greater Mankato Area Somali population. 

During the study, you will take part in a 30-minute session on day 1 in which your blood pressure will be measured. You may be contacted to join two 30-minute follow-up sessions (one at 6 weeks and one at 3 months after day 1). During the follow-up sessions you will be asked about your primary care provider and blood pressure control statuses. Your name may be drawn at random to receive health education and a blood pressure monitor. 

You may be eligible to participate if you are: 

• Somali non-pregnant adult (age 18 or older) in the Greater Mankato area who —
  • Shops at the Mankato Halal Stores and/or
  • Attends the Mosque in Mankato

For questions regarding the study contact Mohamed Ibrahim, MBBS, or Erin Westfall, D.O.

The purpose of this study is to learn about the changes in blood clotting proteins as children age. 

The study will consist of an in-person consent visit with the study coordinator and a blood draw. Children are eligible to return to the clinic for annual blood draws until the age of 18. The research blood draw can be coordinated with clinical draws if applicable. All study costs will be covered and will result in no extra charges to you or your child. We will offer payment for your child's participation. 

You may be eligible to participate if: 

• You are < 18 years of age. 
• Are generally healthy.
• Are taking no medications that affect blood clotting. 
• Are willing to come to an in-person visit at Mayo Clinic in Rochester, Minnesota. 

For questions regarding this study, contact Noelle Drapeau (drapeau.noelle2@mayo.edu or 507-266-6397). 

The purpose of this study is to determine if there are certain cells, or biomarkers, in the blood that can help detect the severity of asthma. 

You may be eligible to participate if: 

• You have a diagnosis of asthma and are not actively sick (e.g., Influenza, COVID-19)
• You have a diagnosis of an allergy without recurrent wheezing or an asthma diagnosis and you rare not actively sick (e.g., Influenza, COVID-19)
• If you do not have or are not suspected to have any known upper/lower respiratory disease and are not actively sick (e.g., Influenza, COVID-19)

Once enrolled in this study, participants will be asked to complete a short questionnaire and provide one blood sample. You may be contacted to provide a second sample at a later time. 

Participants also may be asked to participate in a test that measures their breath. They will receive $25 for participating in the breath test. Results of this test will be available in the participants' medical record.

The risks of this study are minor and include pain, bruising, lightheadedness, and/or fainting. Rarely infection at the site of the needle stick may occur. The goal of the study is to gather information and participation will help doctors understand asthma. Information or samples collected for this study will be sent outside of Mayo Clinic for use by the sponsor of this study, Thermo Fisher Scientific. Samples, will be sent and stored without any identifiable information such as your name, Mayo Clinic number, date of birth, etc.

Study participants will receive $25.00 for each blood draw.

For questions regarding this study, contact Doug Jazdewski (jazdzewski.doug@mayo.edu or 507-266-0245). 

Mayo Clinic is seeking to understand how different interventions may help improve communication among providers, the clinic health care team and patients with communication disabilities (CD) during clinical encounters in primary care. 

You may be eligible to participate if: 

• You are age 18 or older. 
• You are a Mayo Clinic patient being seen at the Baldwin clinic or Mayo Family Clinic Southeast in Rochester, Minnesota, and have an upcoming visit with a primary care provider. 
• You have difficulty communicating or a communication disability. 

The estimated time commitment is approximately 15 minutes for the prescreening questions (completed by phone, Patient Online Services or email), and approximately 35-45 minutes for the enrollment visit (completed either in person or remotely by phone, Patient Online Services or email). Compensation will be provided for time spent in the study. 

This study is not designed to treat any illnesses or to directly improve your health. However, you may potentially benefit as the interventions are aimed at improving health care information delivery to patients with difficulty communicating. Anything we learn from this study may benefit patients in the future. 

For questions regarding this study contact the Family Medicine Study Coordinators by email at rstfmsc@mayo.edu or by telephone at 507-422-6823.

The purpose of this study is to measure sulfoconjugates of vitamin D in breast milk. 

You may be eligible to participate if: 

• You are a currently lactating mother. 
• You are two weeks (or greater) post delivery. 
• You have no intentions of weaning your child during the study. 

You will meet with a study team member and have a 12 mL blood draw. During the visit you will express breast milk in a private location and allow the study team will have one-third of an ounce (10 mL) of the freshly expressed breast milk for the research study. You will be supplied with a 28-day dose of Vitamin D3 (5000 IU) that you will take daily throughout the length of the study. 

Approximately 28 days after your initial visit, you will again meet with a study team member to have a 12 mL blood draw, express breast milk in a private location, and allow the study team to have one-third of an ounce (10 mL) of the freshly expressed breast milk for the study. 

We ask that you bring your personal breast pump and collection container(s) to each visit. 

For questions regarding this study, contact the Family Medicine Study Coordinators by email at rstfmc@mayo.edu or by telephone at 507-422-6823.